Literature DB >> 16230589

Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue.

Bradley A Schiff1, Dianna B Roberts, Adel El-Naggar, Adam S Garden, Jeffrey N Myers.   

Abstract

OBJECTIVES: To assess the role of selective neck dissection in patients with squamous cell carcinoma (SCC) of the oral tongue with advanced nodal disease, and to assess the role of postoperative radiotherapy in patients with SCC of the oral tongue with pathologically N1 necks.
DESIGN: Retrospective study of the medical records of all patients who underwent neck dissection for SCC of the oral tongue from January 1, 1980, to December 31, 1995. Median follow-up was 5.7 years.
SETTING: The University of Texas M. D. Anderson Cancer Center, Houston, a tertiary care cancer hospital. PATIENTS: A total of 220 patients with SCC of the oral tongue who received surgical treatment of both the primary tumor and the neck and who had an identifiable type of neck dissection, no synchronous or metachronous lesions, and no evidence of local recurrence.
INTERVENTIONS: All patients underwent resection of the primary tumor and neck dissection. The extent of neck dissection was determined by surgeon preference. Some patients received radiotherapy to the neck as well. MAIN OUTCOME MEASURES: Clinical and pathological nodal status, type of neck dissection, and use of radiotherapy. The end points evaluated included the regional control rates.
RESULTS: For clinically N+ patients, 5 of 45 treated with selective neck dissection and 1 of 19 treated with radical or modified radical neck dissection had recurrences in the ipsilateral neck. If only patients with significant tumor burden on final pathological examination (clinically N+/pathologically N2) are considered, 4 (25.0%) of 16 patients undergoing selective neck dissection had recurrences in the neck, while none of the 14 patients treated with radical or modified radical neck dissection had recurrences in the ipsilateral neck (P = .07). Of the 50 patients who had pathologically N1 disease, 25 received postoperative radiotherapy and 25 did not. Of the latter, 2 had recurrences in the neck, while none of the 25 patients who received radiotherapy had recurrences in the neck (P = .24).
CONCLUSIONS: Selective neck dissection may be sufficient for many N+ patients with SCC of the oral tongue, but some patients with extensive nodal disease may benefit from more aggressive treatment of the neck. Radiotherapy may be beneficial for all of the node-positive patients, but further studies are needed. Prospective, randomized clinical trials will be useful in further defining the role of selective neck dissection in the clinically N2 neck and radiotherapy in the N1 neck for patients with SCC of the oral tongue.

Entities:  

Mesh:

Year:  2005        PMID: 16230589     DOI: 10.1001/archotol.131.10.874

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  10 in total

1.  Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Authors:  Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

2.  Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design.

Authors:  Maximilian Moergel; Antje Jahn-Eimermacher; Frank Krummenauer; Torsten E Reichert; Wilfried Wagner; Thomas G Wendt; Jochen A Werner; Bilal Al-Nawas
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279

3.  Conversion from selective to comprehensive neck dissection: is it necessary for occult nodal metastasis? 5-year observational study.

Authors:  Sun Min Park; Dong Jin Lee; Eun Jae Chung; Jin Hwan Kim; Il Seok Park; Min Joo Lee; Young Soo Rho
Journal:  Clin Exp Otorhinolaryngol       Date:  2013-06-14       Impact factor: 3.372

4.  Current management of advanced resectable oral cavity squamous cell carcinoma.

Authors:  Thomas J Ow; Jeffrey N Myers
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-03-17       Impact factor: 3.372

5.  Retrospective Study of Selective Submandibular Neck Dissection versus Radical Neck Dissection for N0 or N1 Necks in Level I Patients with Oral Squamous Cell Carcinoma.

Authors:  Yuta Yanai; Tsuyoshi Sugiura; Ikumi Imajyo; Naoya Yoshihama; Naonari Akimoto; Yosuke Kobayashi; Kohei Hayashi; Takahiro Fujinaga; Kanemitsu Shirasuna; Yasuharu Takenoshita; Yoshihide Mori
Journal:  J Oncol       Date:  2012-05-28       Impact factor: 4.375

6.  Trichosanthin cooperates with Granzyme B to restrain tumor formation in tongue squamous cell carcinoma.

Authors:  Zeyao Zhu; Zhenguang Ying; Meiqi Zeng; Qiang Zhang; Guiqing Liao; Yunliu Liang; Chunman Li; Chengfei Zhang; Xia Wang; Weipeng Jiang; Ping Luan; Ou Sha
Journal:  BMC Complement Med Ther       Date:  2021-03-09

Review 7.  Prevalence of Metastasis and Involvement of Level IV and V in Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Ahmad A Altuwaijri; Turki M Aldrees; Mohammed A Alessa
Journal:  Cureus       Date:  2021-12-07

8.  Adjuvant therapy may be omitted for oral cavity cancer with only one positive lymph node.

Authors:  Wan-Yu Chen; Ku-Hao Fang; Chun-Wei Wang; Chun-Ta Liao; Tzu-Chen Yen; Taun-Jen Fang; Shih-Fan Lai; Hsiang-Kuang Liang; Bing-Shen Huang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-10-19

9.  Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.

Authors:  Egon Burian; Benjamin Palla; Nicholas Callahan; Thomas Pyka; Constantin Wolff; Claudio E von Schacky; Annabelle Schmid; Matthias F Froelich; Johannes Rübenthaler; Marcus R Makowski; Felix G Gassert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-24       Impact factor: 10.057

10.  How we do it: a method of neck dissection for histopathological analysis.

Authors:  Tahwinder Upile; Waseem Jerjes; Seyed Ahmad Reza Nouraei; Sandeep Singh; Peter Clarke; Peter Rhys-Evans; Colin Hopper; David Howard; Anthony Wright; Holger Sudhoff; Cyril Fisher; Ann Sandison
Journal:  BMC Surg       Date:  2007-10-31       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.